BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31601252)

  • 21. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
    Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
    Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
    Kang XH; Zhang JH; Zhang QQ; Cui YH; Wang Y; Kou WZ; Miao ZH; Lu P; Wang LF; Xu ZY; Cao F
    Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
    Ma H; Wang L; Zhang T; Shen H; Du J
    Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer.
    Igawa S; Sato Y; Ryuge S; Ichinoe M; Katono K; Hiyoshi Y; Otani S; Nagashio R; Nakashima H; Katagiri M; Sasaki J; Murakumo Y; Satoh Y; Masuda N
    Oncology; 2017; 92(5):283-290. PubMed ID: 28222447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
    Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
    Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.
    Whitsett TG; Mathews IT; Cardone MH; Lena RJ; Pierceall WE; Bittner M; Sima C; LoBello J; Weiss GJ; Tran NL
    Mol Cancer Res; 2014 Apr; 12(4):550-9. PubMed ID: 24469836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer.
    Tanaka F; Takata T; Yamada T; Yanagihara K; Otake Y; Miyahara R; Nakagawa T; Kawano Y; Ishikawa S; Inui K; Wada H
    Lung Cancer; 2002 Apr; 36(1):27-32. PubMed ID: 11891030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.
    Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P
    Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance.
    Luo L; Zhang T; Liu H; Lv T; Yuan D; Yao Y; Lv Y; Song Y
    Med Oncol; 2012 Sep; 29(3):1681-6. PubMed ID: 21993632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
    Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
    Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low LATS2 expression is associated with poor prognosis in non-small cell lung carcinoma.
    Jang SH; Oh MH; Cho H; Lee JH; Lee H; Ahn H; Kim H
    Pol J Pathol; 2019; 70(3):189-197. PubMed ID: 31820862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer].
    Wang DF; Zeng CG; Lin YB; Hou JH; Zhu ZH
    Ai Zheng; 2006 Mar; 25(3):359-62. PubMed ID: 16536995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methionine Aminopeptidase 2 as a Potential Therapeutic Target for Human Non-Small-Cell Lung Cancers.
    Shimizu H; Yamagishi S; Chiba H; Ghazizadeh M
    Adv Clin Exp Med; 2016; 25(1):117-28. PubMed ID: 26935506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014).
    Grossi F; Spizzo R; Bordo D; Cacitti V; Valent F; Rossetto C; Follador A; Di Terlizzi S; Aita M; Morelli A; Fasola G; Consiglieri C; Ceschia T; Beltrami CA; Belvedere O
    J Thorac Oncol; 2010 Sep; 5(9):1354-60. PubMed ID: 20631638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
    Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
    Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical demonstration of apoptosis-regulated proteins, Bcl-2 and Bax, in resected non-small-cell lung cancers.
    Hanaoka T; Nakayama J; Haniuda M; Sato TA
    Int J Clin Oncol; 2002 Jun; 7(3):152-8. PubMed ID: 12109516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.